LENZ
NASDAQ · Pharmaceuticals
Lenz Therapeutics Inc
$4.11
+0.03 (+0.74%)
Open$4.11
Previous Close$4.08
Day High$4.18
Day Low$4.07
52W High$50.40
52W Low$4.01
Volume—
Avg Volume743.6K
Market Cap131.65M
P/E Ratio—
EPS$-4.08
SectorPharmaceuticals
Analyst Ratings
Strong Buy
13 analysts
Price Target
+240.1% upside
Current
$4.11
$4.11
Target
$13.98
$13.98
$9.74
$13.98 avg
$16.17
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 21.12M | 61.59M | 55.54M |
| Net Income | -90,858,474 | 19.38M | 14.59M |
| Profit Margin | -430.3% | 31.5% | 26.3% |
| EBITDA | -100,510,773 | 32.48M | 26.94M |
| Free Cash Flow | — | 24.80M | 19.95M |
| Rev Growth | — | +17.7% | +18.8% |
| Debt/Equity | — | 0.99 | 1.18 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,170.14 | +0.45% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.19 | -0.10% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $150.91 | +0.94% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.93 | +0.68% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.25 | -0.59% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $72.86 | +2.15% | 11.5 | 30.15B |